New: NCI-funded clinical trial search
Mednet Logo
CommunityGynecologic Oncology

Gynecologic Oncology

Clinical discussions on gynecologic malignancies, surgical approaches, and multimodal treatment strategies.

Recent Discussions

If an anatomical defect forms due to rapid disease response from pelvic radiation for large gynecological tumors, is it safe to proceed with a further radiotherapy boost?

4
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would proceed with brachytherapy as planned. For a fistula, if symptomatic, would consider diversion - bilateral nephrostomy or diversion colostomy as needed. Brachytherapy would treat the involved bladder or rectal wall to a therapeutic dose without any needles in the tissue, thereby avoiding any...

What is your general approach to PARPi usage in the front-line and recurrent ovarian cancer setting in light of FDA label changes over the years?

2
1 Answers

Mednet Member
Gynecologic Oncology · Northwestern University Feinberg School of Medicine

In the frontline setting, I generally recommend PARP inhibition with olaparib x2 years for BRCAmut patients (1) and with niraparib x2-3 years for patients with HR-deficient tumors (I personally tend to do 2 years, based on SOLO1 data with olaparib) (2). For BRCAwt patients with HR-proficient tumors...

Do you routinely recommend completion hysterectomy with contralateral salpingo-oophorectomy for patients with a history of fertility-sparing staging for borderline tumor of the ovary who have since completed childbearing?

1
2 Answers

Mednet MemberInvited Expert
Gynecologic Oncology · Froedtert Hospital, Medical College of Wisconsin

Borderline ovarian tumors, also known as atypical proliferative tumors by WHO classification, account for about 10-20% of epithelial ovarian tumors, have histologic subtypes similar to invasive ovarian cancer, and are characterized pathologically by a high degree of proliferation of the epithelial c...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

What is your strategy to prevent and treat constipation in patients initiating or receiving opioids?

4
3 Answers

Mednet Member
Radiation Oncology · Clinical Associate Prof., BC Cancer

I am a radiation oncologist and palliative care physician.I teach: "the hand that writes the opioids, writes the laxatives - or else it does the disimpaction". Opioid induced constipation is very common, can cause physical and psychological discomfort, and have a major impact on quality of life. It ...

With the addition of pembrolizumab following chemoradiation per KEYNOTE-A18, would you be less likely to treat the paraaortic chain prophylactically?

2
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

I would favor the same volume of RT with or without pembro. If there is an indication to treat PA nodal chain, would treat as per plan.

Is there a role for leucovorin in a patient who is 3 days post her most recent treatment dose of methotrexate for GTN, who is experiencing grade 3 mucositis?

1 Answers

Mednet MemberInvited Expert
Gynecologic Oncology · Washington University School of Medicine

I would give it, but it has not been shown to be effective. I just feel like I should do something.

What is your approach to cancer patients who inquire about alternative or complementary treatments?

7
8 Answers

Mednet Member
Radiation Oncology · Mayo Clinic

It depends a little bit on what specifically they want to use, and if they are truly investigating alternative medicine or complementary medicine. For people seeking full alternative medicine without any conventional treatment, I tell them that a research study showed that people who pursued the alt...

For vaginal cuff recurrence of an endometrial cancer, when do you utilize a multichannel cylinder versus single channel cylinder if a patient has <5 mm residual disease after EBRT?

1
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

If disease is confined to one wall, favor MC applicator as I treat vaginal wall thickness for side involved while surface on other side. MC allows that flexibility.Here is the link to our publicationGebhardt et al., PMID 29929925

For an elderly woman with a platinum-resistant recurrence of a high-grade serous ovarian cancer who has been rendered NED surgically, is observation a reasonable approach?

1 Answers

Mednet MemberInvited Expert
Gynecologic Oncology · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Based on her age, performance status, and goals of care, it is certainly reasonable to discuss all options with patients. With her being platinum resistant, I would counsel on prognosis and the need to consider quality of life. With the need for balance between QoL and OS, waiting until there is a m...

How do you manage patients with germline BRCA mutations who have STIC lesions found at the time of risk-reducing BSO?

1 Answers

Mednet MemberInvited Expert
Gynecologic Oncology · Center of Hope

How do you manage patients with germline BRCA mutations who have STIC lesions found at the time of risk-reducing BSO?Most experts agree these are worrisome lesions, likely precursors to high-grade serous carcinoma (HGSC). It is also biologically plausible that the presence of serous tubal intraepith...